BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28
• 29
• 30

• Drug Development

  Actimed Therapeutics announces FDA approval of its Investigational New Drug application for Phase 2b/3 IMPACT clinical trials of S-pindolol benzoate to treat cancer cachexia

  Actimed Therapeutics Ltd announces that it has received approval from the US FDA for its IND application for one Phase 2b/3 clinical study of S-pindolol benzoate to treat cachexia associated with colorectal cancer and another in patients with non-small cell lung cancer.

  September 7, 2023

   · 

  5 min read
• Deals

  Life Science: Cerba HealthCare to Acquire Canadian Contract Research Laboratory CIRION BioPharma Research to Expand Bioanalytical Capabilities and Shorten Time-to-Deploy Complex Clinical Trials

  Cerba HealthCare, a leading global player in medical diagnosis, announced it has acquired CIRION BIOPHARMA RESEARCH INC, a Canadian-controlled private company highly recognized for its integrated bioanalytical and global central laboratory services.

  September 7, 2023

   · 

  6 min read
• SciSparc Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement

  SciSparc Ltd. announced that it has received a notification letter from Nasdaq Stock Market LLC that the Company has been granted an additional 180-day compliance period, or until March 4, 2024 to regain compliance with Nasdaq’s minimum bid price rule.

  September 7, 2023

   · 

  3 min read
• Santhera Announces Half-Year 2023 Financial Results and Provides Corporate Update

  Santhera Pharmaceuticals announces the Company’s financial results for the six months ended June 30, 2023, reports on the regulatory and clinical progress with its lead drug candidate vamorolone for the treatment of DMD, and provides updates on its corporate and financing initiatives.

  September 7, 2023

   · 

  23 min read
• Poxel to Report 2023 First Half-Year Results and host a video conference on September 26, 2023

  POXEL SA announced that it will report its financial results for the Half-Year 2023 on Tuesday, September 26, 2023.

  September 7, 2023

   · 

  2 min read
• Lysando Welcomes Healthcare Visionary Jorge Cortell to its Advisory Board

  Lysando, leading biotech in antimicrobial proteins, proudly announces the addition of Mr. Jorge Cortell to its esteemed Advisory Board marking a significant milestone in the company’s growth.

  September 7, 2023

   · 

  2 min read
• Bio NC

  Fennec Pharmaceuticals to Participate in Upcoming September 2023 Investor Conferences

  Fennec Pharmaceuticals Inc., a commercial stage specialty pharmaceutical company, announced that the Company will be participating in upcoming conferences.

  September 7, 2023

   · 

  5 min read